These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 326495)

  • 1. A preliminary controlled evaluation of the antihypertensive effect of indapamide.
    Turner P; Volans GN; Rogers HJ
    Curr Med Res Opin; 1977; 4(8):596-601. PubMed ID: 326495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
    Ambrosioni E; Safar M; Degaute JP; Malin PL; MacMahon M; Pujol DR; de Cordoüe A; Guez D
    J Hypertens; 1998 Nov; 16(11):1677-84. PubMed ID: 9856369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of indapamide in hypertensive patients failing to respond to a beta-blocker alone.
    O'Boyle CP; Fitzgerald D; Kelly JG; O'Malley K; O'Brien ET
    Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):465-9. PubMed ID: 6492943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of indapamide 1.5 mg, sustained release, in the lowering of systolic blood pressure.
    London GM
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S9-S14. PubMed ID: 15592572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effect of indapamide.
    Gragnoli G; Puccetti F; Nami R; Tanganelli I; Favilli R; Betti E
    Minerva Med; 1977 Mar; 68(12):749-60. PubMed ID: 846677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrarenal contributions to indapamide's antihypertensive mechanism of action.
    Noveck RJ; McMahon FG; Quiros A; Giles T
    Am Heart J; 1983 Jul; 106(1 Pt 2):221-9. PubMed ID: 6869204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
    London G; Schmieder R; Calvo C; Asmar R
    Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic and cardiovascular effects of indapamide in hypertensive subjects: a dose-response curve.
    Leenen FH; Smith DL; Boer WH; Marquez-Julio A
    Curr Med Res Opin; 1983; 8 Suppl 3():47-52. PubMed ID: 6352185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension.
    Matheson AJ; Cheer SM; Goa KL
    Drugs; 2001; 61(8):1211-29. PubMed ID: 11465878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.
    Chaffman M; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Sep; 28(3):189-235. PubMed ID: 6489195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of indapamide on serum and red cell cations, with and without magnesium supplementation, in subjects with mild hypertension.
    Taylor DR; Constable J; Sonnekus M; Milne FJ
    S Afr Med J; 1988 Sep; 74(6):273-6. PubMed ID: 3047887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indapamide versus beta-blocker therapy: a double-blind, crossover study in essential hypertension.
    Rumboldt Z; Rumboldt M; Jurisic M
    Curr Med Res Opin; 1984; 9(1):10-20. PubMed ID: 6373155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
    Mourad JJ; Le Jeune S
    Curr Med Res Opin; 2009 Sep; 25(9):2271-80. PubMed ID: 19627177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indapamide: a review.
    Reyes AJ; Leary WP
    S Afr Med J; 1983 Nov; Suppl():1-6. PubMed ID: 6356402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
    Chalmers J; Castaigne A; Morgan T; Chastang C
    J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
    Laurent S
    J Hypertens Suppl; 2001 Nov; 19(4):S9-14. PubMed ID: 11848262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physicians.
    Schaller MD; Waeber B; Brunner HR
    Clin Exp Hypertens A; 1985; 7(7):985-94. PubMed ID: 3899418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and safety of indapamide in essential hypertension.
    Morledge JH
    Am Heart J; 1983 Jul; 106(1 Pt 2):229-32. PubMed ID: 6346846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indapamide in the treatment of essential arterial hypertension in the elderly.
    Van Hee W; Thomas J; Brems H
    Postgrad Med J; 1981; 57 Suppl 2():29-33. PubMed ID: 7033944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion from 2.5 mg to 1.25 mg indapamide in patients with mild to moderate hypertension.
    Levine B; Lee W; Boyd G; Chrysant S; Dawson J; Gardner T; Hill G; Vergis J; Codispoti J; Stokes A
    J Fam Pract; 1995 Jul; 41(1):75-80. PubMed ID: 7798068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.